[Percutaneous closure of atrial septal defects: midterm results of a new therapeutic strategy].
OBJECTIVE
To evaluate the midterm results of percutaneous closure of the atrial septal defect using two new devices.


METHODS
Nine children (weight 19.7 +/- 7 kg, age 5.1 +/- 1.9 years) underwent percutaneous type II atrial septal defect closure through the antegrade pathway under general anaesthesia, and monitored by transesophageal echocardiography. The closing devices used were DAS-Angel Wings and Ampaltzer.


RESULTS
The hemodynamic results were: mean diameter of the defects was 11.4 +/- 2 mm by TEE measurement and 12.3 +/- 2.6 mm using balloon occlusion reference. Mean pulmonary artery pressure was 12.7 +/- 2 mmHg and mean pulmonary vascular resistance 1.5 +/- 0.5 U/m2. A total of 13 devices were used: 9 Amplatzer and 4 DAS-Angel Wings. Four Amplatzer through the introducer were retrieved without complications. Two of which because of lack of sufficient stability in the atrial septum because they were too small inappropriate and the other two because of inappropriate expansion of distal disk of the device. Finally in all patients the device was a successfully deployed. The angiographic evaluation immediate post-procedure showed a minimal shunt in five patients that was no longer present by color Doppler echocardiography 24 hours later. The children were discharged 38 +/- 12 hours after the procedure and at a mean follow up of 9.6 +/- 2.2 months they remain asymptomatic without any clinical or technical problems.


CONCLUSIONS
With the right selection of patients percutaneous closure of atrial septal defects can obtain a very high success rate without complications.
Zabala Argüelles
J I
JI
Sección de Cardiología Pediátrica, Hospital General Universitario Gregorio Marañón, Madrid.
García
E
E
Zunzunegui Martínez
J L
JL
Maroto Alvaro
E
E
Maroto Monedero
C
C
Greco
R
R
Delcán
J L
JL
D006328:Cardiac Catheterization; D002309:Cardiology / Q000295:instrumentation*; D002648:Child; D002675:Child, Preschool; D017548:Echocardiography, Transesophageal; D006344:Heart Septal Defects, Atrial / Q000628:therapy*; D006801:Humans; D019736:Prostheses and Implants